NCT01336582 Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer Status COMPLETED Phase PHASE1
NCT01317927 A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01315431 A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors Status UNKNOWN Phase PHASE1
NCT01284192 Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) Status COMPLETED Phase PHASE1
NCT01248429 Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases Status COMPLETED Phase N/A
NCT01240590 A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) Status COMPLETED Phase PHASE1/PHASE2
NCT01239381 Individualized Stereotactic Body Radiotherapy of Liver Metastases Status COMPLETED Phase NA
NCT01234012 Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 Status COMPLETED Phase PHASE1
NCT01225536 Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations Status COMPLETED Phase PHASE1
NCT01184326 Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer Status COMPLETED Phase PHASE1
NCT01170897 Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01168011 Safety, Pharmacokinetics and Clinical Activity of Oral Rigosertib in Solid Tumors Status COMPLETED Phase PHASE1
NCT01165905 Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01141257 Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug Status COMPLETED Phase PHASE1
NCT01134250 Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01072266 A Dose-escalation Study in Subjects With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01065805 A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Status TERMINATED Phase PHASE1/PHASE2